|
OMER
|
Omeros Corporation
|
US
|
NASDAQ
|
|
OTIC
|
Otonomy, Inc.
|
US
|
NASDAQ
|
|
OVID
|
Ovid Therapeutics Inc.
|
US
|
NASDAQ
|
|
PHAT
|
Phathom Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
PTPI
|
Petros Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
PXMD
|
PaxMedica, Inc.
|
US
|
NASDAQ
|
|
REGN
|
Regeneron Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
SEEL
|
Seelos Therapeutics, Inc.
|
US
|
NASDAQ
|
|
TNXP
|
Tonix Pharmaceuticals Holding Corp.
|
US
|
NASDAQ
|
|
VTGN
|
VistaGen Therapeutics, Inc.
|
US
|
NASDAQ
|
|
XGN
|
Exagen Inc.
|
US
|
NASDAQ
|
|
ATH
|
Alterity Therapeutics Limited
|
AU
|
ASX
|
|
BNO
|
Bionomics Ltd
|
AU
|
ASX
|
|
CUV
|
Clinuvel Pharmaceuticals Limited
|
AU
|
ASX
|
|
CYC
|
Cyclopharm Limited
|
AU
|
ASX
|
|
MSB
|
Mesoblast limited
|
AU
|
ASX
|
|
NEU
|
Neuren Pharmaceuticals Ltd
|
AU
|
ASX
|
|
PBT
|
Prana Biotechnology Ltd
|
AU
|
ASX
|
|
RGS
|
Regeneus Ltd
|
AU
|
ASX
|
|
RMD
|
ResMed Inc. (CHESS)
|
AU
|
ASX
|